U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06887959) titled 'A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries' on March 19.
Brief Summary: The purpose of this study is to evaluate the effectiveness, safety, and tolerability of SUZ for acute pain after laparoscopic procedures of the intraperitoneal or retroperitoneal cavities or arthroscopic orthopedic procedures.
Study Start Date: March 28
Study Type: INTERVENTIONAL
Condition:
Acute Pain
Intervention:
DRUG: Suzetrigine
Tablets for oral administration.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Vertex Pharmaceuticals Incorporated
Published by HT Digital Cont...